The global parathyroid hormone market size is expected to grow from $2.02 billion in 2021 to $2.15 billion in 2022 at a compound annual growth rate (CAGR) of 6.5%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The parathyroid hormone market is expected to reach $2.51 billion in 2026 at a CAGR of 4%.
What is the Global Parathyroid Hormone Market?
The parathyroid hormone market consists of sales of parathyroid hormones and related services by entities (organizations, sole traders and partnerships) that develop parathyroid hormones to treat various diseases. Parathyroid hormone is responsible for regulating the distribution of phosphate and calcium in the body, and is used in the treatment of diseases such as hypothyroidism and osteoporosis.
Get a Sample of the global parathyroid hormone market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3427&&type=smp
What drives the Global Parathyroid Hormone Market?
The rise in the prevalence of osteoporosis is expected to drive the market for parathyroid hormones. Osteoporosis is a disease characterized by low bone mass and deterioration of bone tissue which further leads to an increased risk of fracture. According to the International Osteoporisis Foundation osteoporosis affects approximately 1.4 million Canadians, mainly postmenopausal women and the elderly. The parathyroid hormone which is naturally produced by the body for regulating the calcium levels is used to reduce the risk of bone fracture in people with osteoporosis and is administered as a daily subcutaneous injection. The increase in osteoporosis is therefore expected to contribute to the growth of the parathyroid hormone market.
Get the full global parathyroid hormone industry report here:
https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report
Global Parathyroid Hormone Market Segments
The global parathyroid hormone market is segmented:
By Disease Type: Hypocalcaemia, Hypoparathyroidism
By End-User: Hospitals, Clinics, Other
By Product Type: Recombinant Parathyroid Hormone, Parathyroid Hormone Analogues
By Geography: The regions covered in the parathyroid hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Parathyroid Hormone Global Market Report 2022provides market size and growth forecasts for the global parathyroid hormone market, global parathyroid hormone market share, parathyroid hormone market segments and geographies, parathyroid hormone market competitive landscape including leading competitors’ revenues, profiles and market shares. The parathyroid hormone market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Global Parathyroid Hormone Industry Playersinclude Pfizer Inc, Eli Lilly and Company, Radius Health Inc, Shire, Ascendis Pharma, Entera Bio Ltd., Extend Biosciences Inc. and Gedeon Richter Plc. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.
